Navigation Links
Molecular Switch in Brain May End Smokers' Cravings
Date:11/24/2008

A key receptor cuts the urge for nicotine, rat study suggests

MONDAY, Nov. 24 (HealthDay News) -- Blocking a neuropeptide receptor in the brain may be one way to quickly lessen the desire for a cigarette, a new study suggests.

Hypocretin-1, or Orexin A, a short chain of amino acids found in nerve tissue, appears to initiate a series of closely linked biochemical reactions that makes lab rats crave nicotine, the addictive chemical in tobacco, according to researchers at the Scripps Florida research institute in Jupiter.

If duplicated in humans, the finding could be lead to new smoking-cessation treatments, the researchers said.

"Blocking hypocretin-1 receptors not only decreased the motivation to continue nicotine use in rats, it also abolished the stimulatory effects of nicotine on their brain reward circuitries," study leader Paul Kenny, a scientist at Scripps Florida, explained in a news release issued by the institute. "This suggests that hypocretin-1 may play a major role in driving tobacco use in smokers to want more nicotine. If we can find a way to effectively block this receptor, it could mean a novel way to help break people's addiction to tobacco."

In the study, the researchers blocked the hypocretin-1 receptor with low doses of the selective antagonist SB-334867, a commercially available compound often used in research.

The results of the study were published in an online early edition of Proceedings of the National Academy of Sciences, released this week.

The findings might explain why some human smokers spontaneously quit smoking after suffering brain damage in a small area of their frontal cortex. Hypocretin-1 receptors are found in the insula, a walnut-size part of the frontal lobe of the brain, the researchers said.

Previous Scripps research found that hypocretin-1 receptors also play a central role in regulating relapse in cocaine addicts.

'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecular Switch in Brain May End Smokers' Cravings
(Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... TripAdvisor as the number one best large hotel for families ... world for their annual Travelers’ Choice Awards. , TripAdvisor ... website is home to millions of unbiased and honest traveler ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method ... lean muscle by up to 30lbs in less than 12 ... HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... scientific diet formula that allows the body to pack on ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2
... the profile for the usage of long-acting contraceptive methods. ... award, shows, amongst other things, that 10% of women ... "Long-acting contraceptives (the IUD, contraceptive injection or contraceptive ... at the Hospital del Mar in Barcelona and author ...
... eyestrain, poor posture, study finds , WEDNESDAY, Oct. 28 ... reduce the level of pain linked to poor posture ... just assume that problems will be solved by purchasing ... It,s also important to make sure the furniture is ...
... A clinical trial for ... Oak, and will open soon at the University of Michigan Comprehensive Cancer Center in Ann Arbor, ... ... women with an aggressive form of metastatic breast cancer is now open at Beaumont Hospital, ...
... ... supplement delivers enhanced speed, growth and productivity while replacing undefined media components such as ... ... 2009 -- InVitria presented the successful performance of its newest CHO cell culture ...
... 28 Two-time Major League Baseball (MLB) Manager ... featured on this month,s episode of Sharing Miracles - ... compelling and inspirational stories of real patients. Sharing Miracles ... stations nationwide. , An iconic figure in baseball, Torre ...
... Minn., Oct. 28 NeuroVasx, Inc., a medical device ... and ischemic stroke, announced today that the first procedure ... performed in Madrid. cPAX received CE Mark earlier this ... Endovascular and Percutaneous Treatment, Clinica Nuestra Senora del Rosario, ...
Cached Medicine News:Health News:The IUD is the most popular long-acting contraceptive amongst Europeans 2Health News:Takes a Pro to Make Offices Pain-Free 2Health News:Beaumont, U-M Open Study of Drug for Advanced Breast Cancer 2Health News:Beaumont, U-M Open Study of Drug for Advanced Breast Cancer 3Health News:Beaumont, U-M Open Study of Drug for Advanced Breast Cancer 4Health News:InVitria Reports Successful Cell Culture Performance of Zap-CHO, a Defined and Cost Effective CHO Cell Culture Media Supplement 2Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 2Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 3Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 4Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 5Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 6Health News:'Sharing Miracles' Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre 7Health News:NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 2Health News:NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 3
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft tissue ... Phase 2 clinical trial.  This open-label study will assess ... (an investigational medication), in approximately 30 adults as first-line ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 is ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... ,, WEST ORANGE, N.J. , May 25 Corneal Associates ... eye care technology.   Dr. Theodore Perl , the visionary surgeon and ... New Jersey the newest innovation in refractive surgery: the iFS™ Advanced Femtosecond ... (Logo:  http://www.newscom.com/cgi-bin/prnh/20100525/DA08463LOGO) , ...
... May 25 Phreesia, the leading patient check-in ... Series D investment. Ascension Health Ventures (AHV) led the ... Industries, Polaris Venture Partners, HLM Venture Partners, and Long River ... Investment Manager at Ascension Health Ventures, will be joining Phreesia,s ...
Cached Medicine Technology:iFS(TM) LASIK at Corneal Associates of New Jersey 2iFS(TM) LASIK at Corneal Associates of New Jersey 3Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures 2Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures 3
Mastisol Liquid Adhesive is a clear, non-irritating, and non-water-soluble liquid adhesive that secures the most difficult dressings for an extended period of time. Mastisol is 7 to 10 times stickier...
... Indermil® tissue adhesive is indicated for the ... incisions, and trauma-induced lacerations in areas of ... and have easily approximated skin edges. In ... adhesive may act as a barrier to ...
The first Ethyl-2-Cyanoacrylate tissue adhesive in a tube that is more economical than sutures!...
... GE Healthcare is ... in best-in-class analysis programs ... area monitoring device. With ... 12SL, Gender-Specific, and ACI-TIPI, ...
Medicine Products: